Dear NNPDF Families and Friends,
We are pleased to share with the foundation's Niemann-Pick Disease type C (NPC) families and community a press release regarding the recently incorporated, Vtesse, a rare disease company spun-off from Cydan Development, Inc.
Vtesse announced today the formation of its Scientific Advisory Board (SAB), to include Niemann-Pick Disease experts Drs. Paul Gissen, Marc Patterson and Forbes D. Porter (who both are currently are on the NNPDF's International SAB), along with biopharmaceutical industry leader Dr. Cristina Csimma, to join Vtesse in their quest to develop new treatments for people facing Niemann-Pick Disease Type C and rare diseases.
Visit the Cyclodextrin page for the full press release: http://www.nnpdf.org/Cyclodextrin.html#VtesseMar25th